ロード中...
Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset
Data from randomized clinical trials have supported the safety and efficacy of intravenous tissue-type plasminogen activator (IV tPA) for acute ischemic stroke when administered within 3 hours of symptom onset, and regulatory approvals for this indication have been in place for almost 20 years. Howe...
保存先:
| 出版年: | Neurohospitalist |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530422/ https://ncbi.nlm.nih.gov/pubmed/26288668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1941874415583116 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|